These stocks aren't popular right now, but their strong underlying businesses make them hot deals to pounce on.

Moderna posted a loss of 51 cents a share for the third quarter, down from a profit of 3 cents last year, but narrower than ...

Pfizer offers a 7% dividend yield, lower COVID sales, oncology and cardiometabolic focus, and growth from Metsera and ...

The greater a company's earnings, the better its position will be to pay dividends. However, Pfizer's adjusted earnings per ...

With big yields, these turnaround stocks look like they are attractively priced for those who can handle some uncertainty.

Novo Nordisk stock reversed higher Wednesday, though the Wegovy and Ozempic maker cut its sales outlook for the third time ...

Management reassured investors that there could be substantial value in its lead drug candidate, VK2735.

A second magnificent ultra-high-yield dividend stock that's begging to be bought in November is pharmaceutical titan Pfizer ( ...

Tokyo’s benchmark Nikkei 225 index tumbled more than 4% on Wednesday and other shares in Asia also sank after a retreat on Wall Street spurred by selling of Big Tech shares. U.S.

The Dow closed 0.5% lower, dropping 251 points, with Nvidia a big loser. The Nasdaq composite suffered the most of the major indexes with a 2% drop. The S&P 500 lost 1.2%. Small-cap stocks on Tuesday ...

Pfizer stock dipped early Tuesday despite hiking its 2025 profit guidance, as third-quarter sales and earnings both toppled ...

Pre-market futures are sinking on valuation concerns this morning. This is not from any particular event that happened this morning, though it may have something to do with events that aren’t ...